Kwok‐Kin Wong
NYU Langone Health(US)Queen's Medical Center(US)Dana-Farber Cancer Institute(US)New York University Florence(IT)National Heart Institute(MY)NYU Langone’s Laura and Isaac Perlmutter Cancer CenterNew York University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, RNA modifications and cancer, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, Epigenetics and DNA Methylation
Most-Cited Works
- → A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations(2010)2,691 cited
- → The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP(2008)2,085 cited
- → Non-small-cell lung cancers: a heterogeneous set of diseases(2014)1,994 cited
- → STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma(2018)1,562 cited
- → Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints(2016)1,544 cited
- → The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins(2013)1,525 cited